Table 3 Logistic regression model on response to induction therapy.

From: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

 

Regression model on response to induction therapy

 

OR

P value

Age above 75 years

0.55

0.030

WBC (>10 × 109/l)

0.26

<0.001

ATO/ATRA

2.21

0.30

Male gender

0.72

0.22

  1. ATO arsenic trioxide, ATRA all-trans retinoic acid, CTX chemotherapy, OR odds ratio, WBC white blood cell count.